Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alessandra Iurlo

Showing results (11-20 of 211) with videos related to

Pageof 22
Sort By:
International Journal of Molecular Sciences|August 23, 2020
New Perspectives on Polycythemia Vera: From Diagnosis to TherapyAlessandra Iurlo, Daniele Cattaneo, Cristina Bucelli, et al.
Expert Review of Hematology|February 15, 2014
Cooperation between pathologists and clinicians allows a better diagnosis of Philadelphia chromosome-negative myeloproliferative neoplasmsUmberto Gianelli, Alessandra Iurlo, Daniele Cattaneo, et al.
Hematological Oncology|September 14, 2024
Treatment-free remission as a new goal in the management of chronic myeloid leukemia: Clinical and biological aspectsDaniele Cattaneo, Cristina Bucelli, Valentina Bellani, et al.
Current Treatment Options in Oncology|December 4, 2023
Cardiovascular Adverse Events of Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia: Clinical Relevance, Impact on Outcome, Preventive Measures and Treatment StrategiesAlessandra Iurlo, Daniele Cattaneo, Cristina Bucelli, et al.
British Journal of Haematology|October 21, 2022
Trend of circulating CD34<sup>+</sup> cells in patients with myelofibrosis: Association with spleen response during ruxolitinib treatmentAlessandra Iurlo, Nicole Galli, Cristina Bucelli, et al.
Frontiers in Oncology|September 30, 2022
Case report: Pleural effusion during tyrosine-kinase inhibitor treatment in chronic myeloid leukemia: Not only a dasatinib-related adverse eventRaffaella Pasquale, Cristina Bucelli, Valentina Bellani, et al.
Clinical Laboratory|February 5, 2015
Three hematologic malignancies in the same patient: chronic lymphocytic leukemia, followed by chronic myeloid leukemia and acute myeloid leukemiaBruno Fattizzo, Tommaso Radice, Daniele Cattaneo, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|April 5, 2016
Anagrelide and Mutational Status in Essential ThrombocythemiaAlessandra Iurlo, Daniele Cattaneo, Nicola Orofino, et al.
Leukemia Research|November 28, 2023
The molecular landscape of myeloproliferative neoplasms associated with splanchnic vein thrombosis: Current perspectiveCarlo Pescia, Gianluca Lopez, Daniele Cattaneo, et al.
Frontiers in Oncology|January 31, 2022
Successful Imatinib Treatment for Systemic Mastocytosis Associated With Myelodysplastic/Myeloproliferative Neoplasm: Report of a Case and Literature ReviewEnrico Barozzi, Cristina Bucelli, Federica Irene Grifoni, et al.
Pageof 22

Showing results (11-20 of 211) with videos related to

Sort By:
Pageof 22
International Journal of Molecular Sciences|August 23, 2020
New Perspectives on Polycythemia Vera: From Diagnosis to TherapyAlessandra Iurlo, Daniele Cattaneo, Cristina Bucelli, et al.
Expert Review of Hematology|February 15, 2014
Cooperation between pathologists and clinicians allows a better diagnosis of Philadelphia chromosome-negative myeloproliferative neoplasmsUmberto Gianelli, Alessandra Iurlo, Daniele Cattaneo, et al.
Hematological Oncology|September 14, 2024
Treatment-free remission as a new goal in the management of chronic myeloid leukemia: Clinical and biological aspectsDaniele Cattaneo, Cristina Bucelli, Valentina Bellani, et al.
Current Treatment Options in Oncology|December 4, 2023
Cardiovascular Adverse Events of Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia: Clinical Relevance, Impact on Outcome, Preventive Measures and Treatment StrategiesAlessandra Iurlo, Daniele Cattaneo, Cristina Bucelli, et al.
British Journal of Haematology|October 21, 2022
Trend of circulating CD34<sup>+</sup> cells in patients with myelofibrosis: Association with spleen response during ruxolitinib treatmentAlessandra Iurlo, Nicole Galli, Cristina Bucelli, et al.
Frontiers in Oncology|September 30, 2022
Case report: Pleural effusion during tyrosine-kinase inhibitor treatment in chronic myeloid leukemia: Not only a dasatinib-related adverse eventRaffaella Pasquale, Cristina Bucelli, Valentina Bellani, et al.
Clinical Laboratory|February 5, 2015
Three hematologic malignancies in the same patient: chronic lymphocytic leukemia, followed by chronic myeloid leukemia and acute myeloid leukemiaBruno Fattizzo, Tommaso Radice, Daniele Cattaneo, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|April 5, 2016
Anagrelide and Mutational Status in Essential ThrombocythemiaAlessandra Iurlo, Daniele Cattaneo, Nicola Orofino, et al.
Leukemia Research|November 28, 2023
The molecular landscape of myeloproliferative neoplasms associated with splanchnic vein thrombosis: Current perspectiveCarlo Pescia, Gianluca Lopez, Daniele Cattaneo, et al.
Frontiers in Oncology|January 31, 2022
Successful Imatinib Treatment for Systemic Mastocytosis Associated With Myelodysplastic/Myeloproliferative Neoplasm: Report of a Case and Literature ReviewEnrico Barozzi, Cristina Bucelli, Federica Irene Grifoni, et al.
Pageof 22